UT Health Science Center-San Antonio: Can HIV Infection Be Prevented? First MRNA Vaccine Study for HIV in San Antonio's History Is Getting Underway
January 28, 2022
January 28, 2022
SAN ANTONIO, Texas, Jan. 28 (TNSRes) -- The University of Texas Health Science Center at San Antonio issued the following news release:
The University of Texas Health Science Center at San Antonio and clinical partner University Health soon will begin a Phase 1 clinical research study of an HIV vaccine candidate produced by Moderna. This will be San Antonio's first-ever study of an mRNA HIV vaccine.
The study, which will enroll up to 15 patients locally, is sponsor . . .
The University of Texas Health Science Center at San Antonio and clinical partner University Health soon will begin a Phase 1 clinical research study of an HIV vaccine candidate produced by Moderna. This will be San Antonio's first-ever study of an mRNA HIV vaccine.
The study, which will enroll up to 15 patients locally, is sponsor . . .